MilliporeSigma expands antibody-drug conjugate manufacturing

By The Science Advisory Board staff writers

September 9, 2020 -- MilliporeSigma is expanding its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) manufacturing capabilities with a $65 million investment at its Madison, WI, facility.

The investment will support large-scale manufacturing of compounds that have the potential to treat cancer. The expansion is expected to be complete by mid-2022 and will add approximately 50 full-time jobs starting in 2021.

MilliporeSigma is expanding its ADC manufacturing capabilities.
MilliporeSigma is expanding its ADC manufacturing capabilities. ADCs are an emerging class of medicines designed for high-specificity targeting and destruction of cancer cells, while preserving healthy ones. Image courtesy of MilliporeSigma.

The new 70,000-sq-ft commercial building will be a dedicated HPAPI manufacturing space designed to handle single-digit nanogram occupation exposure limit materials. The facility will incorporate containment areas to produce next-generation linker and payload materials for ADCs. The facility will add to the company's existing ADC manufacturing capabilities in St. Louis, MO.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here